Croden J, Garcia-Manero G, Chien K, DiNardo C, et al. A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Leuk Lymphoma 2026 Mar 30:1-7. doi: 10.1080/10428194.2026.2650674.
PMID: 41909958